In fact, the CD4+ CFC-iDC showed a higher sensitivity in predicting self-resolving infection (Controller patients), while the CD4+ CFC-pp65 pool showed the best specificity in predicting Non-Controller patients that required treatment for an HCMV infection (Table 2, Figure 6A,G). This evidence concerns the gene CD4 and cytomegalovirus infection.